High Outlier
Strength
5 mg/mL
Manufacturer
Azurity Pharmaceuticals Inc.NDC
52652600102
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
BACLOFENApproval Type
New Drug (NDA)
FDA Application
NDA215602On Market Since
2/7/2022
Pharmacological Classes
Related Drugs
Same classification
No related drugs found.